These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 3719553)

  • 1. Skin reaction to systemic 5-FU -- a therapeutic bonus.
    Omura EF
    N Engl J Med; 1977 Oct; 297(17):946. PubMed ID: 904673
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing an Allergic Reaction.
    Emerson T
    AORN J; 2024 Jan; 119(1):82-84. PubMed ID: 38149905
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
    Kadoyama K; Kuwahara A; Yamamori M; Brown JB; Sakaeda T; Okuno Y
    J Exp Clin Cancer Res; 2011 Oct; 30(1):93. PubMed ID: 21970649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reactions from antineoplastic agents.
    Weiss RB; Baker JR
    Cancer Metastasis Rev; 1987; 6(3):413-32. PubMed ID: 3319275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term intravenous infusion of 5-fluorouracil combined with platidiam in local spread of squamous cell carcinoma of the oral cavity].
    Gorbunova VA; Liubaev VL; Shatikhin VA; Brzhezovskiĭ VZh; Pustynskiĭ IN
    Sov Med; 1989; (5):92-4. PubMed ID: 2675338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity].
    Poruban D; Koza I; Mracna J; Nagy V; Vasko J
    Bratisl Lek Listy; 1992 Aug; 93(8):395-400. PubMed ID: 1464019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma.
    Yanamoto S; Umeda M; Kioi M; Kirita T; Yamashita T; Hiratsuka H; Yokoo S; Tanzawa H; Uzawa N; Shibahara T; Ota Y; Kurita H; Okura M; Hamakawa H; Kusukawa J; Tohnai I
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):549-554. PubMed ID: 29383483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
    Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
    J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic reaction to 5-fluorouracil infusion.
    Sridhar KS
    Cancer; 1986 Aug; 58(4):862-4. PubMed ID: 3719553
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.